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Pyroptosis is an inflammasome-induced lytic cell death mode, the physiological role of which in chronic inflammatory 
diseases is unknown. Familial Mediterranean Fever (FMF) is the most common monogenic autoinflammatory disease 
worldwide, affecting an estimated 150,000 patients. The disease is caused by missense mutations in Mefv that activate 
the Pyrin inflammasome, but the pathophysiologic mechanisms driving autoinflammation in FMF are incompletely 
understood. Here, we show that Clostridium difficile infection of FMF knock-in macrophages that express a chimeric 
FMF-associated MefvV726A Pyrin elicited pyroptosis and gasdermin D (GSD MD)–mediated interleukin (IL)-1β secretion. 
Importantly, in vivo GSD MD deletion abolished spontaneous autoinflammatory disease. GSD MD-deficient FMF knock-in 
mice were fully protected from the runted growth, anemia, systemic inflammatory cytokine production, neutrophilia, and 
tissue damage that characterize this autoinflammatory disease model. Overall, this work identifies pyroptosis as a critical 
mechanism of IL-1β–dependent autoinflammation in FMF and highlights GSD MD inhibition as a potential antiinflammatory 
strategy in inflammasome-driven diseases.
GSD MD is critical for autoinflammatory pathology in 
a mouse model of Familial Mediterranean Fever
Apurva Kanneganti1,2,3,4,5, R.K. Subbarao Malireddi6, Pedro H.V. Saavedra1,2, Lieselotte Vande Walle1,2, Hanne Van Gorp1,2, Hiroto Kambara4,5, 
Heather Tillman7, Peter Vogel7, Hongbo R. Luo4,5, Ramnik J. Xavier3,8, Hongbo Chi6, and Mohamed Lamkanfi1,2
Introduction
Inflammasomes are intracellular multiprotein complexes that 
serve as platforms for activation of caspase-1 (Lamkanfi and 
Dixit, 2014; Man and Kanneganti, 2016). Pyroptosis is rapidly 
emerging as a key mechanism by which caspase-1 and the related 
inflammatory caspases-4, -5, and -11 contribute to host defense 
against bacterial infections (Jorgensen and Miao, 2015; Vande 
Walle and Lamkanfi, 2016). These inflammatory caspases induce 
pyroptosis by cleaving gasdermin D (GSD MD) at the central 
linker peptide, thereby separating the pore-forming amino-ter-
minal domain (GSD MDN) from the inhibitory carboxy-terminal 
(GSD MDC) domain (Kayagaki et al., 2015; Shi et al., 2015; Aglietti 
et al., 2016; Ding et al., 2016). This cleavage event causes GSD 
MDN to oligomerize and insert in the plasma membrane, giving 
rise to a rapid loss of plasma membrane integrity and cell lysis. 
Pyroptosis deprives intracellular pathogens from their replica-
tive niches and traps infectious agents in the cellular debris of 
infected cells to facilitate bacterial clearance by recruited neu-
trophils (Jorgensen et al., 2016). Moreover, it is thought to pro-
mote the extracellular release of the nuclear alarmin HMGB1 and 
the inflammatory cytokines IL-1β and IL-18 during infections 
(Lamkanfi et al., 2010; Kayagaki et al., 2015; Shi et al., 2015). Akin 
to GSD MD, IL-1β and IL-18 are inflammasome substrates that are 
produced as biologically inert precursor proteins that are stored 
in the cytosol until they undergo proteolytic conversion into the 
mature, secreted cytokines after inflammasome assembly. Con-
trary to GSD MD, however, pro–IL-1β and pro–IL-18 are specifi-
cally cleaved by caspase-1, but not other inflammatory caspases.
As key regulators of both innate and adaptive immunity, IL-1β 
and IL-18 not only are central to coordinating antimicrobial host 
defense, but these cytokines also play central roles in autoimmune 
and autoinflammatory diseases (Garlanda et al., 2013; Gurung and 
Kanneganti, 2016; Van Gorp et al., 2017). Familial Mediterranean 
fever (FMF) is the most prevalent monogenic autoinflammatory 
disease worldwide, and it has a particularly high prevalence of 
1:500 to 1:1,000 among individuals of Middle Eastern and Medi-
terranean descent (Ozen and Bilginer, 2014). The large majority 
of FMF patients carry mutations in the carboxy-terminal B30.2 
(PRY/SPRY) domain of the human inflammasome sensor Pyrin, 
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encoded by Mefv (Ozen and Bilginer, 2014), and the field has 
recently witnessed tremendous progress in understanding the 
mechanisms regulating activation of the Pyrin inflammasome 
(Xu et al., 2014; Gao et al., 2016; Masters et al., 2016; Park et 
al., 2016; Van Gorp et al., 2016). FMF mutations in the carboxy- 
terminal B30.2 domain were recently demonstrated to render 
Pyrin inflammasome activation independent of microtubules 
(Van Gorp et al., 2016), but the physiological mechanisms driv-
ing FMF pathogenesis are still largely unknown. An important 
hurdle for modeling FMF in preclinical animal models is that the 
rodent orthologue of human Pyrin lacks the carboxy-terminal 
B30.2 (PRY/SPRY) domain that is frequently mutated in FMF 
patients. However, previous studies showed that knock-in mice 
engineered to express a chimeric Pyrin protein from the endoge-
nous Mefv locus that is composed of full-length mouse Pyrin and 
an FMF-associated mutant human B30.2 domain spontaneously 
develop IL-1 receptor–dependent autoinflammation that is res-
cued by deletion of the central inflammasome adaptor protein 
ASC (Chae et al., 2011). In agreement with clinical evidence 
showing a detrimental role for IL-1β production in FMF patients 
(Ozdogan and Ugurlu, 2017), autoinflammatory pathology in 
these knock-in mice expressing the common MefvV726A FMF 
mutation was selectively driven by IL-1β, but not IL-1α (Sharma 
et al., 2017). Considering the key role of IL-1β in FMF and other 
inflammatory diseases, a key outstanding question is what mech-
anisms are responsible for IL-1β secretion under conditions that 
promote chronic inflammatory disease. Numerous mechanisms 
for secretion of IL-1β have been proposed in this respect, includ-
ing lysosomal exocytosis (Andrei et al., 1999), exosome exocytosis 
(Qu et al., 2007), microvesicle shedding (MacKenzie et al., 2001), 
and alternative inflammasome activation (Gaidt et al., 2016), but 
studies addressing the physiological roles of these IL-1β secretory 
pathways in autoinflammatory and autoimmune disease in vivo 
have not been reported.
Here, we explore the hypothesis that IL-1β–dependent auto-
inflammation in the MefvV726A/V726A FMF mouse model is driven 
by pyroptotic cytokine release. We showed that the pyroptosis 
effector GSD MD is cleaved concomitantly with IL-1β in ex vivo–
cultured MefvV726A/V726A macrophages that had been infected 
with Clostridium difficile and that GSD MD deletion dampens 
extracellular release of IL-1β. Importantly, we demonstrate 
that in vivo GSD MD deletion fully rescued autoinflammation- 
associated growth retardation, anemia, cytokine production, 
neutrophilia, and tissue damage in MefvV726A/V726A FMF mice. 
Overall, this work establishes pyroptosis as a critical in vivo 
mechanism of autoinflammation and thus suggests that pyro-
ptosis inhibition may prevent inflammasome-dependent auto-
inflammatory and autoimmune pathology.
Results and discussion
Pyroptosis contributes to IL-1β secretion ex vivo from C. 
difficile–infected MefvV726A/V726A macrophages
Bone marrow–derived macrophages (BMDMs) of MefvV726A/V726A 
mice were infected with C. difficile to analyze inflammasome- 
induced maturation of caspase-1 and the pyroptosis executioner 
GSD MD because this Gram-positive, toxin-producing bacterial 
pathogen was recently shown to activate the Pyrin inflammasome 
in human peripheral blood mononuclear cells (PBMCs) and 
mouse macrophages (Van Gorp et al., 2016). Unlike in nonin-
fected cells, significant cleavage of caspase-1 and GSD MD was 
observed in C. difficile–infected BMDMs (Fig. 1 A). Consistent 
with potent Pyrin inflammasome activation under these exper-
imental conditions, we detected significant levels of secreted 
IL-1β in the culture supernatants (Fig. 1 B). C. difficile infection 
also triggered robust induction of cell death, with nearly all 
MefvV726A/V726A macrophages being labeled by the cell-imperma-
nent fluorescent dye Sytox green 25 h after infection (Fig. 1 C). 
The cell death response was pyroptotic in nature because genetic 
deletion of GSD MD markedly diminished the fraction of Sytox 
green–positive MefvV726A/V726A macrophages after C. difficile 
infection (Fig.  1  C). Moreover, pyroptosis contributed to IL-1β 
secretion because culture supernatants of GSD MD-deficient 
MefvV726A/V726A macrophages contained significantly less IL-1β 
than GSD MD-sufficient cells when probed at 8 h and 20 h after 
infection, respectively (Fig. 1, D and E). Western blotting analy-
sis of culture supernatants and whole cell lysates confirmed that 
MefvV726A/V726A Gsdmd−/− macrophages matured IL-1β, which 
mostly was retained intracellularly, whereas the bulk of the 
mature cytokine was retrieved in the culture medium of GSD 
MD-sufficient MefvV726A/V726A macrophages (Fig. 1 F). Although 
GSD MD deletion did not abolish cytokine secretion, these results 
identify pyroptosis as an important mechanism contributing to 
IL-1β secretion from ex vivo–infected MefvV726A/V726A macro-
phages. Because GSD MD-deficient macrophages were shown 
to undergo apoptosis after inflammasome activation (He et al., 
2015), it is likely that residual TcdA-induced IL-1β release from 
GSD MD-deficient macrophages could be associated with induc-
tion of secondary necrosis after apoptotic cell death ex vivo.
Pyroptosis is essential for systemic IL-1β release and 
inflammatory cytokine production in vivo
Recurrent fever and systemic autoinflammation appear unpro-
voked and are not associated with infections in FMF patients. To 
address the in vivo role of pyroptosis in secretion of IL-1β in a 
more physiologically relevant context of autoinflammation, we 
measured the levels of IL-1β in serum of MefvV726A/V726A mice 
that were either sufficient or deficient in GSD MD expression. 
Consistent with previous studies (Chae et al., 2011; Sharma et al., 
2017), we measured significant levels of IL-1β in serum of 4- to 
7-wk-old MefvV726A/V726A mice, but not in heterozygous litter-
mate control mice (Fig. 2 A). Notably, deletion of GSD MD fully 
abolished in vivo IL-1β production in serum of MefvV726A/V726A 
mice aged 4–7 wk (Fig. 2 A), which contrasted markedly to the 
continued release of IL-1β in culture media of BMDMs that had 
been infected with C. difficile ex vivo (Fig. 1). MefvV726A/V726A mice 
aged 10 wk and older continued to present with high IL-1β con-
centrations in their blood, whereas pyroptosis-deficient litter-
mate mice had only background IL-1β levels (Fig. 2 A), identifying 
pyroptosis as the central mechanism of chronic IL-1β release in 
the circulation of MefvV726A/V726A mice. Because MefvV726A/V726A 
mice were shown to produce a suite of inflammatory cytokines 
and chemokines in an IL-1β–dependent manner (Sharma et al., 
2017), we further examined how GSD MD deficiency impacts on 
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serum levels of a panel of inflammatory cytokines and chemo-
kines. GSD MD deletion abrogated IL-1β–dependent production 
of IL-6, TNF, IL-18, IL-17A, RAN TES, MCP-1, IFN-γ, IP-10, G-CSF, 
and other inflammatory mediators in MefvV726A/V726A mice (Fig. 
S1), further supporting the critical role of pyroptosis in sys-
temic IL-1β release and autoinflammation-associated cytokine 
production. Consistent with Pyrin inflammasome activation in 
vivo, we found that caspase-1 and GSD MD were constitutively 
activated in peritoneal macrophages and circulating monocytes 
of MefvV726A/V726A mice, but not in cells of MefvV726A/+ littermate 
mice (Fig.  2, B and C). Ex vivo incubation of isolated perito-
neal macrophages and blood monocytes in culture media fur-
ther enhanced cleavage of caspase-1 and GSD MD. We similarly 
observed constitutive activation of the Pyrin inflammasome in 
granulocytes of MefvV726A/V726A mice, unlike in the neutrophilic 
fraction of MefvV726A/+ littermate mice (Fig. S2). Together, these 
results demonstrate that FMF-associated mutations in Mefv 
promote constitutive Pyrin inflammasome activation, GSD MD 
maturation, and pyroptosis-dependent systemic inflammation 
in MefvV726A/V726A mice.
Pyroptosis causes neutrophilia, runting, and wasting disease 
in MefvV726A/V726A mice
To further assess the role of GSD MD in IL-1β–mediated auto-
inflammation, we examined signs of systemic neutrophilia, 
which is typically involved in the clinical manifestation of 
FMF (Ozen and Bilginer, 2014). Consistent with reported find-
ings (Chae et al., 2011; Sharma et al., 2017), flow cytometry 
analysis indicated that MefvV726A/V726A mice had a markedly 
increased proportion of Gr-1+CD11b+ polymorphonuclear leu-
kocytes (PMNs) in their blood (Fig. 3 A). Absolute PMN counts 
were also increased in autoinflammatory MefvV726A/V726A mice 
(Fig.  3  B), consistent with the systemic neutrophilia seen in 
FMF patients. Mice lacking GSD MD on either a wild-type or 
Figure 1. Pyroptosis contributes to IL-1β 
secretion from ex vivo C. difficile–infected 
MefvV726A/V726A macrophages. (A and B) BMDMs 
from MefvV726A/V726A mice were infected with 
C. difficile (10 MOI) for 20 h. Cell lysates were 
immunoblotted for caspase-1 and GSD MD (A), 
and culture supernatants were analyzed for 
IL-1β (B). (C–E) BMDMs from MefvV726A/V726A and 
MefvV726A/V726AGsdmd−/− littermate mice were 
infected with C. difficile (10 MOI), and induction 
of pyroptosis was quantified over time by mon-
itoring Sytox green incorporation (C). Culture 
supernatants were analyzed for IL-1β levels at 
8 h (D) and 20 h (E) after infection. (F) BMDMs 
were infected with C. difficile during 8 h before 
culture supernatants (SN) and whole cell lysates 
(WCL) were immunoblotted for IL-1β, GSD MD, 
and β-actin. Bands are denoted with black arrows 
and the corresponding size. All data are repre-
sentative of three independent experiments, and 
cytokine data are presented as mean ± SD from 
a representative experiment out of three per-
formed with n = 3 in each repeat. p in Western 
blots denotes protein molecular weight.
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autoinflammatory MefvV726A/V726A genetic background were 
indistinguishable from heterozygous MefvV726A/+ control mice, 
presenting with baseline neutrophil counts (Fig.  3, A and B). 
MefvV726A/V726A mice and littermate mice that lacked GSD MD 
expression were scored regularly for clinical markers of disease 
progression, including body weight, skin scaling, and runting 
at weaning (when aged 4 wk) until they became 9 wk old. As 
expected (Chae et al., 2011; Sharma et al., 2017), from the onset 
of our measurements and continued throughout the observed 
period, MefvV726A/V726A mice did display a markedly lower body 
weight as compared with that of heterozygous MefvV726A/+ 
control mice (Fig. 3 C). In sharp contrast, MefvV726A/V726A mice 
that lacked GSD MD expression presented with normal body 
weight (Fig.  3  C) and appeared fully protected from runting, 
skin lesions, tail deformities, and muscle wasting that was 
readily seen in autoinflammatory MefvV726A/V726A mice (Fig. 3 D 
and not depicted). Moreover, defective pyroptosis induction 
fully protected MefvV726A/V726A mice from anemia, as evident 
from measurement of blood hemoglobin and hematocrit levels 
(Fig. 3 E). Together, these results identify pyroptosis as a key 
mechanism driving the clinical pathogenesis of IL-1β–mediated 
autoinflammatory disease.
Figure 2. Pyrin-induced pyroptosis is essential for 
systemic IL-1β secretion in MefvV726A/V726A mice. (A) 
Levels of IL-1β in serum samples taken from littermate 
mice of the indicated genotypes that were aged 4–7 wk 
and 10–14 wk at the time of analysis. Data are presented 
as mean ± SEM with n = 4–13 for each genotype. Data 
points are color coded according to the mouse genotypes 
shown in the corresponding figure legend. P < 0.05 is 
considered statistically significant. **, P < 0.01 and ****, 
P < 0.0001 using unpaired Student’s t test and two-tailed 
p-values. ns, not significant. (B and C) Blood monocytes 
and peritoneal macrophages from littermate mice of the 
indicated genotypes and age were immunoblotted for 
caspase-1, GSD MD, and β-actin upon collection or after 
incubation in culture media for the indicated duration. 
Data are representative for three independent exper-
iments. p in Western blots denotes protein molecular 
weight. Data are representative of three independent 
experiments with n = 3 in each repeat (B and C).
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MefvV726A/V726A-associated histopathology is 
dependent on GSD MD
Neutrophilia in FMF usually is accompanied by leukocyte infil-
tration and splenomegaly. These disease traits were all observed 
in MefvV726A/V726A mice, but genetic deletion of GSD MD fully pre-
vented splenomegaly (Fig. 4 A), as also confirmed by comparison 
of spleen weight of the respective genotypes (Fig. 4 B). More-
over, the loss of GSD MD protected MefvV726A/V726A mice against 
all observed histological perturbations, including evidence of 
multifocal moderate hepatitis in the liver, multifocal moderate 
glomerulonephritis in the kidney, diffuse moderate to marked 
colitis in the colon, diffuse moderate intravascular granulocyto-
sis in the lung, and diffuse marked granulocytopoiesis and mark-
edly reduced erythropoiesis in bone marrow and diffuse marked 
periarticular suppurative inflammation in the knee (Fig. 4 C). 
MefvV726A/V726A mice also displayed signs of organ damage such 
Figure 3. GSD MD promotes neutrophilia, runting, and wasting disease in MefvV726A/V726A mice. (A) Representative dot plot depicting the proportion 
of neutrophils (CD11b+Gr1+), distinguished by high CD11b+ values, in blood of littermate mice of the indicated genotypes. The percentage of cells identified 
as neutrophils is depicted on each plot. (B) Levels of neutrophils and PMNs in blood of littermate mice and nonlittermate GSD MD knockout mice. Data are 
presented as mean ± SEM with n = 7–17 for each genotype. (C) Body weight of female littermate mice of the indicated genotypes was analyzed weekly when 
mice were 4 wk old until aged 9 wk. Data are presented as mean ± SEM with n = 5–14 for each genotype. (D) Representative photos of littermate mice of the 
indicated genotypes are shown. (E) Levels of hemoglobin and hematocrit are shown as a measure of anemia in littermate mice of the indicated genotypes. Data 
are presented as mean ± SEM with n = 5–20 for each genotype. Data points are color coded according to the mouse genotypes shown in the corresponding 
figure legend. P < 0.05 is considered statistically significant. ****, P < 0.0001 using unpaired Student’s t test and two-tailed p-values (B, C, and E). Data are 
representative of two independent experiments (A–E). ns, not significant.
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as bile duct hyperplasia in the liver, glomerulopathy, necrosis, 
and proteinosis in the kidney and mucosal hyperplasia in the 
colon. Histological scoring by an experienced pathologist who 
was blinded to the experimental groups confirmed that these 
clinical features of organ damage were fully rescued by genetic 
deletion of GSD MD (Fig. S3).
Histological analysis of H&E-stained spleen sections further 
revealed that GSD MD deletion blunted the extramedullary hema-
topoiesis and normalized the aberrant morphology of the periar-
teriolar lymphoid sheaths and follicle regions in the white pulp 
areas of MefvV726A/V726A spleens (unpublished data). To study 
these changes in additional detail, we performed immunohisto-
chemical analysis of spleen sections to characterize splenocyte 
cell types and distribution. The white pulp areas of the spleen 
normally contain T cells in the periarteriolar lymphoid sheaths 
and B cells in the follicles. However, these areas were indistinct 
in spleens of MefvV726A/V726A mice and showed evidence of plasma 
cell hyperplasia, including an abundant presence of IRF4+ plasma 
cells containing large globules of immunoglobulins that are 
known as Mott cells (Fig. 5, A and B). This was accompanied by 
marked decreases in numbers of B220+ B cells, CD4+ T cells, and 
CD8+ T cells. Macrophage counts in the spleens of MefvV726A/V726A 
mice did not differ notably from those seen in heterozygous con-
trol mice, but their macrophages displayed an activated morphol-
ogy that was characterized by a more amoeboid and less dendritic 
cytoplasm and an enlarged nucleus (unpublished data). The 
increased erythropoiesis in the spleens of MefvV726A/V726A mice is 
most likely a result of displacement by increased granulocytosis 
in the bone marrow. Notably, these alterations were all absent in 
spleens of MefvV726A/V726AGsdmd−/− mice (Fig. 5, A and B). Alto-
gether, these results support the concept that GSD MD drives the 
clinical manifestation of FMF-associated pathology by promoting 
pyroptotic release of IL-1β.
IL-1β is a pleiotropic cytokine that plays a central role in coor-
dinating inflammatory, wound-healing, and antimicrobial host 
defense responses during infections. However, unabated and 
chronic IL-1β production may also be pathogenic to patients, as 
illustrated by the remarkable efficacy of approved IL-1β–neu-
tralizing biologics in patients suffering from a suite of arthritic 
and autoinflammatory diseases (Hoffman and Broderick, 2016). 
Moreover, results from a recent multicentered, double-blind, 
placebo-controlled clinical study further highlighted the detri-
mental role of chronic IL-1β production in postinfarction heart 
failure in patients with inflammatory atherosclerosis (Ridker et 
al., 2017a), and other findings suggest that IL-1β neutralization 
might significantly reduce the risk for lung cancer and lung can-
cer–associated mortality (Ridker et al., 2017b). Several mecha-
nisms that control IL-1β secretion have been put forward, includ-
ing lysosomal exocytosis (Andrei et al., 1999), exosome exocytosis 
(Qu et al., 2007), microvesicle shedding (MacKenzie et al., 2001), 
and alternative inflammasome activation (Gaidt et al., 2016), but 
studies addressing their roles in autoinflammation and autoim-
munity have not been reported.
Here, we demonstrated that pyroptosis partially accounts 
for IL-1β secretion from MefvV726A/V726A macrophages that 
have been infected ex vivo with the Gram-positive bacterial 
pathogen C. difficile, suggesting that additional mechanisms 
contribute to IL-1β secretion under these experimental con-
ditions. Remarkably, however, genetic deletion of the central 
pyroptosis effector protein GSD MD fully rescued autoinflam-
matory MefvV726A/V726A mice from spontaneous IL-1β–driven 
autoinflammatory pathology. GSD MD deficiency not only 
ablated circulating levels of IL-1β, but fully protected against all 
clinical hallmark symptoms of autoinflammatory pathology in 
MefvV726A/V726A mice, including runting, anemia, inflammatory 
cytokine and chemokine secretion, neutrophilia, splenomegaly, 
and systemic tissue damage. Thus, we have shown a crucial role 
for pyroptosis in driving autoinflammatory pathology in FMF. 
This work thus clearly delineates the dominant contribution 
of GSD MD-mediated pyroptosis to IL-1β–dependent pathology 
in this mouse model of FMF-associated autoinflammation and 
suggests that pyroptosis may similarly exert a crucial role in 
the etiology of other chronic IL-1β–mediated autoinflammatory 
and autoimmune diseases. Analogous studies to the ones pre-
sented here may shed light on the relative contribution of GSD 
MD and pyroptosis to additional IL-1β–dependent autoinflam-
matory and autoimmune pathologies, including cryopyrin-as-
sociated periodic syndromes (Brydges et al., 2009) and spon-
taneous HA20-associated inflammatory arthritis in mice with 
a myeloid-restricted deletion of A20/TNF AIP3 (Vande Walle 
et al., 2014). Additionally, exploration of the role of pyropto-
sis in autoimmune and autoinflammatory diseases associated 
with high circulating levels of IL-18 and DAMPs, such as S100 
proteins and HMGB1, is warranted. Such studies might further 
highlight the potential of pyroptosis inhibition as an antiin-
flammatory strategy in diverse chronic diseases.
Materials and methods
Mice
We thank D.L. Kastner (National Institutes of Health, Bethesda, 
MD) for providing MefvV726A/+ mice and V.M. Dixit and N. 
Kayagaki (Genentech, South San Francisco, CA) for provid-
ing Gsdmd−/− mice (Chae et al., 2011; Kayagaki et al., 2015). 
MefvV726A/+ mice were bred to Gsdmd−/− mice to generate 
MefvV726A/V726AGSD MD−/− mice. Mice were housed in individ-
ually ventilated cages and were maintained in specific patho-
gen-free facilities of Ghent University and St. Jude Children’s 
Research Hospital. Animal studies were approved by the ethics 
committees on laboratory animal welfare of Ghent University 
and St. Jude Children’s Research Hospital Committees on the Use 
and Care of Animals.
Tissue processing and analysis
Mice were monitored weekly for weight gain starting from 4 wk 
of age and euthanized when aged 8–12 wk for systemic analyses. 
Blood was collected through cardiac puncture and retroorbital 
bleeding, and 50 µl was added to anticoagulant EDTA for cellu-
lar analysis. The spleen was homogenized and passed through 
a 40-µm filter to obtain a single-cell suspension. Both blood 
and spleen were subjected to RBC lysis and washed in complete 
media. Left lobes of lung were homogenized, filtered, and sub-
jected to a 33% Percoll (GE) gradient centrifugation to remove 
debris and obtain single cell suspension.
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Figure 4. Autoinflammation-associated histo-
pathology in MefvV726A/V726A mice is dependent 
on GSD MD. (A and B) Representative photos; 
bar represents 1 cm (A) and weight (B) of spleens 
of littermate mice of the indicated genotypes. 
Spleen weight is presented as mean ± SEM with 
n = 3–4 for each genotype. Bar graph is color coded 
according to the mouse genotypes shown in the 
corresponding figure legend. P < 0.05 is consid-
ered statistically significant. ***, P < 0.001 and 
****, P < 0.0001 using unpaired Student’s t test 
and two-tailed p-values. ns, not significant. (C) 
Representative sections of H&E-stained liver, kid-
ney, colon, lung, bone marrow, and knee tissue are 
shown. Bars: (liver, kidney, colon, lung, and bone 
marrow) 50 µm; (knee) 500 µm. Original magnifi-
cation is indicated. Histology scores are provided 
in Fig. S3. Data are representative of two indepen-
dent experiments (A–C).
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Figure 5. Pyroptosis drives altered splenocyte cell types and distribution in MefvV726A/V726A mice. (A) The organization and cell types of the spleen of 
littermate mice of the indicated genotypes was compared by immunohistochemistry with antibodies against plasma cells (IRF4), B cells (B220), and T cells 
(CD4 and CD8). Representative micrographs are shown. Bars, 50 µm in all panels. (B) Scoring of IHC slides that were digitized using an Aperio ScanScope XT 
(Leica Biosystems) for quantifying the areas of IRF4, B220, CD4, and CD8 labeling in serial sections of the spleens and to measure the areas of the spleens and 
splenic follicles. Bars are color coded according to the mouse genotypes shown in the corresponding figure legend. *, P < 0.05 (considered statistically signif-
icant); **, P < 0.01; and ***, P < 0.001 using unpaired Student’s t test and two-tailed p-values. ns, not significant. Data are representative of two independent 
experiments with n = 3 for each group (A and B).
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Flow cytometry
The following antibodies were used for cell surface staining: 
CD11b (M1/70), CD19 (6D5), CD3 (17A2), and Gr-1 (RB6-8C5; all 
from eBiosciences). Cells were stained, run on LSR II flow cytom-
eter (BD Biosciences), and analyzed with FlowJo software version 
10.2 (Flowjo LLC). After removal of doublets, B cells were gated 
as CD19+ and T cells as CD3+; CD11b+ and PMN (CD11b+Gr1+) were 
gated on cells negative for both CD3 and CD19.
Histology and immunohistochemistry
All tissues were fixed in formalin, embedded in paraffin, sec-
tioned at 5 µm, mounted on positively charged glass slides 
(Superfrost Plus; Thermo Fisher Scientific), and dried at 60°C for 
20 min before dewaxing and staining with H&E using standard 
methods. H&E-stained sections were examined by a pathologist 
blinded to the experimental group assignments. Scores were 
assigned based on inflammation, ulceration, hyperplasia, and the 
extent or severity of damage. Severity scores for colon inflamma-
tion were assigned as follows: 0 = normal (within normal limits); 
2 = minimal (mixed inflammation, small, focal, or widely sep-
arated, limited to lamina propria); 15 = mild (multifocal mixed 
inflammation, often extending into submucosa); 40 = moderate 
(large multifocal lesions within mixed inflammation involving 
mucosa and submucosa); 80 = marked (extensive mixed inflam-
mation with edema and erosions); 100 = severe (diffuse inflam-
mation with transmural lesions and multiple ulcers). Scores for 
ulceration were assigned as follows: 0 = normal (none); 2 = min-
imal (only one small focus of ulceration involving <5 crypts); 15 
= mild (a few small ulcers up to 5 crypts); 40 = moderate (multi-
focal ulcers up to 10 crypts); 80 = marked (multifocal to coalesc-
ing ulcers involving >10 crypts each); 100 = severe (extensive to 
diffuse with multiple ulcers covering >20 crypts each). Scores 
of hyperplasia were assigned as follows: 0 = normal; 2 = mini-
mal (some areas with crypts elongated and increased mitoses); 
15 = mild (multifocal areas with crypts elongated up to twice the 
normal thickness, normal goblet cells present); 40 = moderate 
(extensive areas with crypts up to twice the normal thickness, 
reduced goblet cells); 80 = marked (mucosa over twice the normal 
thickness, hyperchromatic epithelium, reduced or rare goblet 
cells, possibly foci of arborization); 100 = severe (mucosa twice 
the normal thickness, marked hyperchromasia, crowding or 
stacking, absence of goblet cells, high mitotic index and arboriza-
tion). Scores of extents were assigned as follows: 0 = normal (rare 
or inconspicuous lesions); 2 = minimal (<5% involvement); 15 = 
mild (multifocal but conspicuous lesions, 5–10% involvement); 
40 = moderate (multifocal, prominent lesions, 10–50% involve-
ment); 80 = marked (coalescing to extensive lesions or areas of 
inflammation with some loss of structure, 50–90% involvement); 
100 = severe (diffuse lesion with effacement of normal structure, 
>90% involvement).
For immunohistochemical staining of the spleen, the pri-
mary antibodies used in this study included the following: for 
plasma cells, anti-IRF4 (1:300 dilution; sc-6059; Santa Cruz Bio-
technology); for B cells, anti-B220 (1:1,000 dilution; 553084; BD 
PharMingen); and for T cells, anti-CD4 (4SM95; 1:40 dilution; 
14-9766; Thermo Fisher Scientific) and anti-CD8 (1:40 dilution; 
14-0808-82; Thermo Fisher Scientific). For detection of CD4 and 
B220, sections underwent antigen retrieval at 100°C for 20 min 
in Epitope Retrieval solution 2 on a Bond Max immunostainer 
(Leica Biosystems). Then biotinylated secondary rabbit anti–
rat antibody diluted 1:400 (BA-4001; Vector Laboratories) was 
applied for 10 min followed by Bond polymer refine detection 
kit with 3,3′-diaminobenzidine (DAB) as chromogenic substrate 
and a hematoxylin counterstain (DS9800; Leica Biosystems). 
For detection of IRF4, CD8, and Iba1, tissue sections underwent 
antigen retrieval in a prediluted Cell Conditioning Solution (CC1; 
Ventana Medical Systems) for 32 min. For anti-CD8, a biotinylated 
secondary rabbit anti–goat antibody (1:400; BA-5000; Vector 
Laboratories) was applied for 10 min, whereas for anti-IRF4 the 
OmniMap anti–rabbit HRP kit (Ventana Medical Systems) was 
used for detection. Discovery Fast Red was the chromogen for 
CD8 and ChromoMap DAB for IRF4, B220, and CD4 (both from 
Ventana Medical Systems).
Macrophage differentiation and C. difficile infection
Macrophages were differentiated by culturing bone marrow pro-
genitor cells in IMDM (Lonza) containing 10% (vol/vol) heat-in-
activated FBS, 30% (vol/vol) L929 cell-conditioned medium, 1% 
(vol/vol) nonessential amino acids (Lonza), 100 U/ml penicillin, 
and 100 mg/ml streptomycin at 37°C in a humidified atmosphere 
containing 5% CO2 for 6 d. BMDMs were then seeded into µ-Slide 
8-well (Ibidi) or in multiple well plates as needed in IMDM con-
taining 10% FBS, 1% nonessential amino acids, and antibiotics. 
C. difficile strain VPI10463 (toxigenic; TcdA+TcdB+) was pur-
chased from ATCC. Glycerol stocks were cultured overnight 
at 37°C in anaerobic conditions in BHIS (brain–heart infusion 
supplemented with yeast extract)-enriched medium (37 g/liter 
brain–heart infusion, Gibco; 5 g/liter yeast extract, Gibco; 0.03% 
l-cysteine, Sigma; 0.1% sodium taurocholate, Sigma). Infections 
were performed at 10 multiplicity of infection (MOI).
Cell death kinetic measurements (IncuCyte)
Sytox green permeability was used to quantify pyroptosis over 
time using CellEvent Caspase3/7 green substrate (Invitro-
gen) according to the manufacturer’s instructions. Data were 
acquired and analyzed using the IncuCyte Zoom system (Essen-
bio) over a time span of 25 h. Each condition was run in (techni-
cal) duplicates.
Western blotting
Unless otherwise stated, cell lysates and culture supernatants 
were combined for Western blotting. Protein samples were dena-
tured in Laemmli buffer, boiled at 95°C for 10 min, separated by 
SDS-PAGE, and transferred to polyvinylidene difluoride mem-
branes. PBS supplemented with 0.05% Tween-20 (vol/vol) and 
3% nonfat dry milk (wt/vol) was used for blocking and washing 
of membranes. Immunoblots were incubated overnight with pri-
mary antibodies against caspase-1 (AG-20B-0042-C100; 1:1,000; 
Adipogen), GSD MD (1:1,000; Genentech; Aglietti et al., 2016), 
or IL-1β (GTX74034; 1:3,000; Genetex), followed by HRP-conju-
gated secondary antibodies raised against mouse, goat, or rab-
bit (1:5,000). The β-actin–HRP antibody was used at 1:5,000 in 
PBS 0.1% Tween-20 and 5% nonfat dry milk. All proteins were 
detected by enhanced chemiluminescence.
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Cytokine analysis
Cytokine levels were determined in serum and cell culture super-
natants by magnetic bead–based multiplex assay using Luminex 
technology (Bio-Rad) and ELI SA kits that were obtained from 
eBiosciences and Millipore, respectively. GraphPad Prism 6.0 
software was used for data analysis. Data are represented with 
standard deviation (SD).
Statistical analysis
Statistical analysis was performed using GraphPad Prism 6.05 
software. Student’s t test or one-way ANO VA was used with Fisch-
er’s least significance difference or Dunn’s posttest, as indicated. 
Two-way ANO VA was used to analyze the kinetics of body weight 
gain and spleen composition. In most analyses, MefvV726A/+ mice 
were used as a control to analyze the degree of disease or protec-
tion. P-value < 0.05 was considered significant.
Online supplemental material
Fig. S1 shows that GSD MD is critical for IL-1β–dependent sys-
temic inflammatory cytokine production in MefvV726A/V726A mice. 
Fig. S2 shows that caspase-1 and GSD MD are cleaved in granulo-
cytes of MefvV726A/V726A mice. Fig. S3 shows the histology scores 
and inflammatory tissue damage in MefvV726A/V726A mice from 
the representative sections of H&E-stained tissues provided 
in main Fig. 4 C.
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